ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS

The article presents mechanism of action of abatacept, literature data on clinical studies of its effectiveness in adults with rheumatoid arthritis, and results of clinical randomized double-blinded placebo-controlled study of abatacept effectiveness in treatment of different types of juvenile idiop...

Full description

Saved in:
Bibliographic Details
Main Authors: E.I. Alexeeva, R.V. Denisova, S.I. Valieva, T.M. Bzarova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2009-07-01
Series:Вопросы современной педиатрии
Online Access:https://vsp.spr-journal.ru/jour/article/view/1148
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242310472105984
author E.I. Alexeeva
R.V. Denisova
S.I. Valieva
T.M. Bzarova
author_facet E.I. Alexeeva
R.V. Denisova
S.I. Valieva
T.M. Bzarova
author_sort E.I. Alexeeva
collection DOAJ
description The article presents mechanism of action of abatacept, literature data on clinical studies of its effectiveness in adults with rheumatoid arthritis, and results of clinical randomized double-blinded placebo-controlled study of abatacept effectiveness in treatment of different types of juvenile idiopathic arthritis. The analysis of literature data showed that abatacept is new perspective medication for the treatment of rheumatoid arthritis in adults and children.Key words: children, rheumatoid arthritis, abatacept, treatment.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(4):84-89)
format Article
id doaj-art-cf714286b4dd4ba197da5dc2fdd07c2e
institution Kabale University
issn 1682-5527
1682-5535
language English
publishDate 2009-07-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-cf714286b4dd4ba197da5dc2fdd07c2e2025-08-20T03:59:52Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352009-07-018484891149ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITISE.I. Alexeeva0R.V. Denisova1S.I. Valieva2T.M. Bzarova3Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowThe article presents mechanism of action of abatacept, literature data on clinical studies of its effectiveness in adults with rheumatoid arthritis, and results of clinical randomized double-blinded placebo-controlled study of abatacept effectiveness in treatment of different types of juvenile idiopathic arthritis. The analysis of literature data showed that abatacept is new perspective medication for the treatment of rheumatoid arthritis in adults and children.Key words: children, rheumatoid arthritis, abatacept, treatment.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(4):84-89)https://vsp.spr-journal.ru/jour/article/view/1148
spellingShingle E.I. Alexeeva
R.V. Denisova
S.I. Valieva
T.M. Bzarova
ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
Вопросы современной педиатрии
title ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
title_full ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
title_fullStr ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
title_full_unstemmed ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
title_short ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
title_sort abatacept new opportunities in treatment of juvenile idiopathic arthritis
url https://vsp.spr-journal.ru/jour/article/view/1148
work_keys_str_mv AT eialexeeva abataceptnewopportunitiesintreatmentofjuvenileidiopathicarthritis
AT rvdenisova abataceptnewopportunitiesintreatmentofjuvenileidiopathicarthritis
AT sivalieva abataceptnewopportunitiesintreatmentofjuvenileidiopathicarthritis
AT tmbzarova abataceptnewopportunitiesintreatmentofjuvenileidiopathicarthritis